Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06352307
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-04-02
Brief Title:
Risk Stratification Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
Sponsor:
First Affiliated Hospital Xian Jiaotong University
Organization:
First Affiliated Hospital Xian Jiaotong University
Study Overview
Official Title:
Risk Stratification Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy STARTER a Multicenter Retro-prospective Cohort Study
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STARTER
Brief Summary:
This study will include patients diagnosed with Arrhythmogenic cardiomyopathy ACM in the First Affiliated Hospital of Xi an Jiaotong University and other centers and collect clinical data and biological samples of patients with different ACM phenotypes Through the establishment of disease cohort and long-term follow-up to explore the disease characteristics development law clinical characteristics natural course of disease and long-term prognosis of ACM
Detailed Description:
This study will include patients diagnosed with Arrhythmogenic cardiomyopathy ACM in the First Affiliated Hospital of Xi an Jiaotong University and other centers and collect clinical data and biological samples of patients with different ACM phenotypes Through the establishment of disease cohort and long-term follow-up to explore the disease characteristics development law clinical characteristics natural course of disease and long-term prognosis of ACM
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None